Filing Details
- Accession Number:
- 0001209191-13-058670
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-26 17:01:04
- Reporting Period:
- 2013-12-23
- Filing Date:
- 2013-12-26
- Accepted Time:
- 2013-12-26 17:01:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1103021 | Biodelivery Sciences International Inc | BDSI | Pharmaceutical Preparations (2834) | 352089858 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1066040 | Jr E Francis Odonnell | C/O Biodelivery Sciences Intl, Inc. 801 Corporate Center Drive, Suite 210 Raleigh NC 27607 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-12-23 | 100,000 | $5.91 | 2,771,751 | No | 4 | J | Indirect | By HCG II LLC |
Common Stock | Disposition | 2013-12-23 | 50,000 | $5.88 | 2,721,751 | No | 4 | S | Indirect | By HCG II LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | J | Indirect | By HCG II LLC |
No | 4 | S | Indirect | By HCG II LLC |
Footnotes
- The subject shares, which were held indirectly by the Reporting Person through Hopkins Capital Group II, LLC, were involuntarily transferred by Hopkins Capital Group II, LLC to a lender of Hopkins Capital Partners, Inc. under a pledge and account control agreement between the lender and Hopkins Capital Partners, Inc. The lender exercised its rights to take title to such shares in exchange for a reduction in Hopkins Capital Partners, Inc.?s secured indebtedness equal to $5.91 per transferred share.
- These shares are owned by Hopkins Capital Group II, LLC, of which the Reporting Person is the Manager.
- On December 23, 2013, the Reporting Person sold an aggregate of 50,000 shares of the Issuer's Common Stock at a weighted average price of $5.88. The highest sale price for the Common Stock was $5.95 per share and the lowest sale price was $5.86 per share.